Mary-Helen Barcellos-Hoff

12PUBLICATIONS
68CO-AUTHORS
Radiation therapyMolecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 04, 2025
Plasma Proteomic Analysis Reveals Complement System Changes in Irradiated Female BALB/c Mice during Mammary Carcinogenesis.

Tina Akbarzadeh, Lin Ma, Jingyun Lee

|May 19, 2025
Revisiting the TGFβ paradox: insights from HPV-driven cancer and the DNA damage response.

Mary Helen Barcellos-Hoff, Sue S Yom

|Mar 06, 2025
Identification of a conserved subset of cold tumors responsive to immune checkpoint blockade.

Jade Moore, Jim Gkantalis, Ines Guix

|Oct 10, 2024
Super-enhancer profiling reveals ThPOK/ZBTB7B, a CD4 + cell lineage commitment factor, as a master regulator that restricts breast cancer cells to a luminal non-migratory phenotype.

Camila D Arcuschin, Kamin Kahrizi, Rosalyn W Sayaman

|Jun 26, 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.

Fabiana Gregucci, Sheila Spada, Mary Helen Barcellos-Hoff

|Jan 04, 2023
Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy.

Mary Helen Barcellos-Hoff, James L Gulley

Pageof 2

Frequent Collaborators

4 joint publications

Jade Moore

3 joint publications

William Chou

2 joint publications

Jian-Hua Mao

2 joint publications

Sue S Yom